Lumexa Imaging Holdings, Inc. (LMRI) income statement
LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.06+0.05 (+0.36%)
Close on Nov 19, 2026Market cap $1.35BP/E –Yield –
Lumexa Imaging Holdings, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 1.52
- Debt to equity
- 1.32
- Debt to assets
- 45.7%
- Cash to current liabilities
- 49.1%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.13
- Dividend yield
- –
See a number that looks wrong?